Carol A. Vallone

CIK: 0001422058

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)1 (33.3%)

Derivative conversions

Awards (A)2 (66.7%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

DFTX

Definium Therapeutics, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (3 total)

DFTX
Definium Therapeutics, Inc.
Sep 18, 2026
Exercise(M)
Direct
1.1K shares at avg. $35.52$39K
DFTX
Definium Therapeutics, Inc.
Jun 11, 2026
Award(A)
Direct
4.7K shares-
MNMD
Mind Medicine (MindMed) Inc.
Jun 12, 2025
Award(A)
Stock Option (Right to Buy)
Direct
75.2K shares-

		Type	Shares	Price		Ownership
Sep 18, 2026	DFTX Definium Therapeutics, Inc.	Exercise(M)	1,086	$35.52	$38,575	Direct
Jun 11, 2026	DFTX Definium Therapeutics, Inc.	Award(A)	4,666	-	$0	Direct
Jun 12, 2025	MNMD Mind Medicine (MindMed) Inc.	Award(A) Stock Option (Right to Buy)	75,187	-	-	Direct

1-3 of 3 transactions

About Vallone Carol A

Vallone Carol A (SEC CIK 0001422058) files insider reports with the SEC as Director of Definium Therapeutics, Inc. (DFTX).

Signal8 holds 3 ownership filings by Vallone Carol A, all Form 4s, filed between Jun 16, 2025 and Sep 18, 2026. Those filings report 3 transactions, from Jun 12, 2025 to Sep 18, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Vallone Carol A's filings is in NEW YORK, NY.

Recent filings by Vallone Carol A

Sep 18, 2026: Option exercise of DFTX shares (Form 4, code M).
Jun 11, 2026: Grant or award of DFTX shares (Form 4, code A).
Jun 12, 2025: Grant or award of MNMD derivative securities (Form 4, code A).

Other insiders filing for Definium Therapeutics, Inc. (DFTX)

Karlin Daniel, Chief Medical Officer
Barrow Robert, Chief Executive Officer
Wiley Matthew T., Chief Commercial Officer
Sullivan Mark, Chief Legal Officer
Roberts Brandi, Chief Financial Officer
Krebs Andreas, Director

How to read Form 4 transaction codes